Sonnet BioTherapeutics Holdings, Inc. (SONN) Balance sheet
Market cap
$1.26
P/E ratio
| 2013/12 | 2014/12 | 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/09 | 2021/09 | 2022/09 | 2023/09 | 2024/09 | 2025/09 | |
| Cash and cash equivalents | 442,694 | 245,828 | 2 | - | - | 630,206 | - | - | - | - | - | 0 | 5 |
| Total cash & short-term investments | 442,694 | 245,828 | 2 | - | - | 630,206 | - | - | - | - | - | 0 | 5 |
| Accounts receivable, net | 227,181 | 276,734 | 882,263 | 524,481 | 475,988 | 387,239 | - | - | - | - | - | - | - |
| Inventories | 381,408 | 532,803 | 726,624 | 539,550 | 460,756 | 478,314 | 287,111 | - | - | - | - | - | - |
| Total current assets | 2 | 1 | 4 | 2 | 2 | 2 | 1 | 8 | 29 | 5 | 5 | 2 | 14 |
| Property, plant and equipment, net | 6 | 13 | 17 | 12 | 9 | 10 | 6 | 67,889 | 59,056 | 46,211 | 33,366 | 20,523 | 10,906 |
| Marketable securities, non-current | - | 35,362 | 31,322 | 800,000 | 800,000 | 800,000 | - | - | - | - | - | - | - |
| Total assets | 20 | 36 | 42 | 33 | 30 | 30 | 32 | 8 | 29 | 6 | 5 | 3 | 15 |
| Accounts payable | - | - | - | - | - | - | - | 2 | 4 | 5 | 2 | 2 | 3 |
| Long-term debt, current | 700,168 | 2 | 5 | 6 | 6 | 4 | 7 | - | - | - | - | - | - |
| Total current liabilities | 6 | 11 | 16 | 12 | 15 | 14 | 18 | 5 | 7 | 8 | 6 | 3 | 4 |
| Long-term debt, non-current | 178,565 | 5 | 1 | 287,445 | - | 3 | - | - | - | - | - | - | - |
| Total liabilities | 9 | 21 | 20 | 20 | 19 | 22 | 35 | 5 | 7 | 8 | 6 | 3 | 4 |
| Retained earnings | -14,472,816 | -20,876,187 | -33,012,713 | -42,206,325 | -49,109,303 | -57,124,673 | -75,068,385 | -36,705,257 | -61,689,218 | -91,411,059 | -110,243,753 | -117,680,985 | -133,692,472 |
| Stockholders' equity | 11 | 15 | 22 | 14 | 11 | 8 | -3,152,011 | 3 | 22 | -2,538,719 | -225,980 | -485,739 | 11 |